|

GM-CSF (Sargramostim) Clinical Trials

1 actively recruiting trial across 1 location

Also known as: GM-CSF, Hepatic Immunoembolization, Leukine, Sargramostim, yeast-derived recombinant human GM-CSF

Pipeline

Phase 1/2: 1

Top Sponsors

  • Thomas Jefferson University1

Indications

  • Liver Disease1
  • Metastatic Uveal Melanoma1
  • Liver Cancer1
  • Cancer1

Philadelphia, Pennsylvania1 trial

Tebentafusp-tebn With LDT in Metastatic UM

Thomas Jefferson University

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.